TrialNature medicine2024

Regorafenib plus nivolumab in unresectable hepatocellular carcinoma: the phase 2 RENOBATE trial.

Hyung-Don Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.